A six-months-old healthcare O2O (online-to-offline) start-up founded by Shanghai Pharmaceuticals Holding Co., Ltd. has completed RMB1.112 (US$174 million) series A funding with participation from JD.com Inc. and IDG Capital Partners, according to a securities filing. Shanghai Pharmaceuticals, listed on the city's stock exchange, is leading the round, injecting RMB900 million (US$141 million) via a share […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network